Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Staab

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Journal of Health and Hospital Law : a Publication of the American Academy of Hospital Attorneys of the American Hospital Association|December 9, 1994
Is there a private cause of action under COBRA for misdiagnosis?M J Staab
Ear and Hearing|August 1, 1989
American Auditory Society--reemphasis of missionW J Staab
British Journal of Audiology|August 1, 1990
Digital/programmable hearing aids--an eye towards the futureW J Staab
Acta Gastro-Enterologica Belgica|January 1, 1987
The combined use of CA 19-9 and carcino-embryonic antigen (CEA) in malignancies of the gastrointestinal tractH J Staab
Naunyn-Schmiedebergs Archiv Fur Pharmakologie|January 1, 1970
[Participation of the basic side-chain of phenothiazine derivatives in their albumin binding]J Staab, J Krieglstein
International Archives of Allergy and Applied Immunology|January 1, 1975
A new reliable method for evaluation of foot pad swelling as an experimental in vivo immune phenomenonG Ströbel, H J Staab
British Journal of Cancer|October 1, 1978
Chemical modification and immunogenicity of membrane fractions from mouse tumour cellsH J Staab, F A Anderer
British Journal of Cancer|April 1, 1977
Immunogenicity of tumour cells modified with various chemicalsH J Staab, F A Anderer
International Archives of Allergy and Applied Immunology|January 1, 1982
Preferential induction of cell-mediated immunity by chemically modified carcinoembryonic antigenH J Staab, F A Anderer
Cancer Detection and Prevention|January 1, 1984
Immunotherapy of tumor-bearing mice with chemically modified tumor membrane fractions of two syngeneic tumor cell linesH J Staab, F A Anderer
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Journal of Health and Hospital Law : a Publication of the American Academy of Hospital Attorneys of the American Hospital Association|December 9, 1994
Is there a private cause of action under COBRA for misdiagnosis?M J Staab
Ear and Hearing|August 1, 1989
American Auditory Society--reemphasis of missionW J Staab
British Journal of Audiology|August 1, 1990
Digital/programmable hearing aids--an eye towards the futureW J Staab
Acta Gastro-Enterologica Belgica|January 1, 1987
The combined use of CA 19-9 and carcino-embryonic antigen (CEA) in malignancies of the gastrointestinal tractH J Staab
Naunyn-Schmiedebergs Archiv Fur Pharmakologie|January 1, 1970
[Participation of the basic side-chain of phenothiazine derivatives in their albumin binding]J Staab, J Krieglstein
International Archives of Allergy and Applied Immunology|January 1, 1975
A new reliable method for evaluation of foot pad swelling as an experimental in vivo immune phenomenonG Ströbel, H J Staab
British Journal of Cancer|October 1, 1978
Chemical modification and immunogenicity of membrane fractions from mouse tumour cellsH J Staab, F A Anderer
British Journal of Cancer|April 1, 1977
Immunogenicity of tumour cells modified with various chemicalsH J Staab, F A Anderer
International Archives of Allergy and Applied Immunology|January 1, 1982
Preferential induction of cell-mediated immunity by chemically modified carcinoembryonic antigenH J Staab, F A Anderer
Cancer Detection and Prevention|January 1, 1984
Immunotherapy of tumor-bearing mice with chemically modified tumor membrane fractions of two syngeneic tumor cell linesH J Staab, F A Anderer
Pageof 8